Yahoo · Jul 8, 2026
European Stocks Close Sharply Lower in Wednesday Trading; Oil Prices Spike as US-Iran War Reignites
The European stock markets closed sharply lower in Wednesday trading after fighting between the US a
SB
OTC · SBHMY
Sino Biopharmaceutical Limited
Healthcare · Biotechnology
$13.01
Up+$0.00 (+0.00%)
Updated Aug 18, 2026, 12:42 PM
SID Score
5.7/10
Composite research score
Smart Money
46/100
Neutral
- Market cap
- 16.29B
- P/E ratio
- 28.63
- Dividend yield
- 1.77%
- 52-week range
- — – —
- Volume
- 128
- Avg. volume
- 30
Price performance
SBHMY price history
1M range · 0 trading sessions · Daily adjusted prices
SBHMY does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest SBHMY news
The latest Smart Investors Daily articles mentioning SBHMY.
Stock researchCompany · Overview
SBHMY research
Overview
Company profile and research snapshot.
Company profile
SINO BIOPHARM UNSP/ADR
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $7.71
- Implied upside
- —
- Analysts
- 31
News briefing
No generated briefing is available yet.
Yahoo · Jul 8, 2026
AstraZeneca, GSK intensify China ties with Sino Biopharm deals
The U.K. drugmakers added to a series of recent tie-ups with Chinese counterparts amid broader scrutiny of such transactions in the U.S.
Yahoo · Nov 10, 2025
MediTrust Health and Sino Biopharm Sign Strategic Cooperation Agreement at CIIE 2025 to Advance Drug-Insurance Integration New Model
Shanghai, November 10, 2025 – During the 8th China International Import Expo (CIIE), Sino Biopharmaceutical Limited ("Sino Biopharm") and Shanghai MediTrust Health Technology Group Co., Ltd. ("MediTrust Health") signed a strategic cooperation agreement. The two parties will carry out in-depth cooperation around innovative drugs and commercial insurance, jointly explore a new model of drug-insurance integration, and help more patients access high-quality, affordable medicines at an earlier stage.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
